The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000540.3(RYR1):c.8310+1G>T

CA405677313

1253809 (ClinVar)

Gene: RYR1
Condition: RYR1-related myopathy
Inheritance Mode: Autosomal recessive inheritance
UUID: 847fc8d2-7c8a-4ccd-9c7a-f48721b307ce
Approved on: 2024-08-07
Published on: 2024-10-01

HGVS expressions

NM_000540.3:c.8310+1G>T
NM_000540.3(RYR1):c.8310+1G>T
NC_000019.10:g.38505082G>T
CM000681.2:g.38505082G>T
NC_000019.9:g.38995722G>T
CM000681.1:g.38995722G>T
NC_000019.8:g.43687562G>T
NG_008866.1:g.76383G>T
ENST00000599547.6:c.8310+1G>T
ENST00000359596.8:c.8310+1G>T
ENST00000355481.8:c.8310+1G>T
ENST00000359596.7:c.8310+1G>T
ENST00000360985.7:c.8307+1G>T
ENST00000594335.5:c.1762+1G>T
NM_000540.2:c.8310+1G>T
NM_001042723.1:c.8310+1G>T
NM_001042723.2:c.8310+1G>T
More

Pathogenic

Met criteria codes 3
PP4 PM3_Strong PVS1
Not Met criteria codes 3
BA1 PM2 BS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Congenital Myopathies Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RYR1 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Congenital Myopathies VCEP
The c.8310+1G>T (NM_000540.3(RYR1):c.8310+1G>T) variant in RYR1 occurs within the canonical splice donor site (+1) of intron 52. It is predicted to cause skipping of biologically-relevant exon 52, resulting in a frameshift leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). The highest population minor allele frequency in gnomAD v4.1 is 0.00001336 (1/74870 alleles) in the African/African American population (PM2_Supporting, BS1, and BA1 are not met). This variant has been detected in at least 2 individuals with autosomal recessive RYR1-related myopathy. For both of those individuals, they were compound heterozygous for the variant and a pathogenic/likely pathogenic variant and both of those were confirmed in trans by parental testing (PM3_strong; SCV002012482; GeneDx and HudsonAlpha Institute for Biotechnology Internal Data; PMID: 34930662). At least one patient with this variant displayed neonatal hypotonia, and reduced mobility of facial muscles and extremities, which is highly specific for autosomal recessive RYR1-related myopathies (PP4; SCV002012482; GeneDx and HudsonAlpha Institute for Biotechnology Internal Data; PMID: 34930662). In summary, this variant meets the criteria to be classified as pathogenic for autosomal recessive RYR1-related myopathies based on the ACMG/AMP criteria applied, as specified by the ClinGen Congenital Myopathies VCEP: PVS1, PM3_Strong, PP4 (Congenital Myopathies VCEP specifications Version 1; 8/7/2024).
Met criteria codes
PP4
At least one patient with this variant displayed neonatal hypotonia and reduced mobility of muscles, which is highly specific for autosomal recessive RYR1-related myopathies. (PP4; GeneDx and HudsonAlpha Institute of Biotechnology Internal Data).
PM3_Strong
This variant has been detected in at least 2 individuals with autosomal recessive RYR1-related myopathy. For both of those individuals, they were compound heterozygous for the variant and a pathogenic/likely pathogenic variant and both of those were confirmed in trans by parental testing (NM_000540.3:c.10348-6C>G; GeneDx and AlphaHudson Institute for Biotechnology; PM3_strong).
PVS1
The c.8310+1G>T(NM_000540.3(RYR1):c.8310+1G>T) variant in RYR1 occurs within the canonical splice donor/acceptor site (+1) of intron 52. It is predicted to cause skipping of biologically-relevant exon 52, resulting in a frameshift leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1).
Not Met criteria codes
BA1
The highest population minor allele frequency in gnomAD v4.1 is 0.00001336 (1/74870 alleles) in the African/African American population. (PM2_Supporting, BS1, and BA1 are not met)
PM2
The highest population minor allele frequency in gnomAD v4.1 is 0.00001336 (1/74870 alleles) in the African/African American population. (PM2_Supporting, BS1, and BA1 are not met)
BS1
The highest population minor allele frequency in gnomAD v4.1 is 0.00001336 (1/74870 alleles) in the African/African American population. (PM2_Supporting, BS1, and BA1 are not met)
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.